Form 4: Charles Schwab Director Sells Shares Under Pre-Arranged Trading Plan

Carolyn Schwab-Pomerantz, a Director at Charles Schwab Corp., reported the sale of 24,000 shares of common stock on July 3, 2025, executed through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carolyn Schwab-Pomerantz, a Director at Charles Schwab Corp. (SCHW), reported the sale of 24,000 shares of common stock.
• The sales occurred on July 3, 2025, and were executed under a Rule 10b5-1 trading plan adopted on August 14, 2024.
• A block of 14,400 shares was sold at a weighted average price of $91.5906 per share, with trades ranging from $91.10 to $91.85.
• Another block of 9,600 shares was sold at a weighted average price of $91.5885 per share, with trades ranging from $91.095 to $91.84.
• Following these transactions, Carolyn Schwab-Pomerantz beneficially owns 1,491,598.6599 shares indirectly through a Trust and 469,714 shares indirectly through a Spouse as Trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can be viewed negatively, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic trading, indicating a pre-planned financial management decision rather than a reaction to new company-specific information.

Positives

• The stock sales were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted on August 14, 2024, which demonstrates a commitment to compliant insider trading practices and reduces the perception of opportunistic selling.

Negatives

• A Director's sale of 24,000 shares, even if pre-planned, could be perceived by some investors as a signal of reduced confidence, although this is mitigated by the Rule 10b5-1 plan.

Risks

• Potential negative investor sentiment if the market misinterprets the pre-planned insider sale as a lack of confidence in the company's future performance.

Future Outlook

No specific forward-looking statements or guidance regarding the company's performance or strategic direction are provided in this filing, as it primarily details an insider stock transaction.

Industry Context

Insider stock transactions, particularly those executed under Rule 10b5-1 plans, are a common practice across all industries for executives and directors to manage their personal equity holdings in a compliant manner. This filing is consistent with standard financial industry practices for managing insider stock sales.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan for insider stock sales is a widely accepted best practice in corporate governance, aligning with standards observed across major financial institutions and publicly traded companies.
• The disclosure of weighted average sale prices for multiple trades within a range ($91.10 to $91.85 and $91.095 to $91.84) is standard for large block transactions and provides transparency consistent with industry norms.

Corporate Governance

Related Party Transactions

• Sale of common stock by Carolyn Schwab-Pomerantz, a Director of Charles Schwab Corp., which constitutes a related party transaction.
• Continued indirect beneficial ownership of shares through a Trust and by Spouse as Trustee, representing related party holdings.

Stakeholder Impact

• Shareholders may view the insider sale with caution, but the pre-arranged nature under a Rule 10b5-1 plan helps to alleviate concerns about the underlying health or prospects of the company.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.

Next Steps

• No specific future actions or milestones for Charles Schwab Corp. are mentioned in this insider transaction report.

Key Dates

Keywords

Charles Schwab, SCHW, Form 4, insider trading, stock sale, director, Rule 10b5-1, beneficial ownership